These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Identification of small molecule inhibitors of anthrax lethal factor. Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925 [TBL] [Abstract][Full Text] [Related]
49. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395 [TBL] [Abstract][Full Text] [Related]
50. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor. Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881 [TBL] [Abstract][Full Text] [Related]
51. Protein- and DNA-based anthrax toxin vaccines confer protection in guinea pigs against inhalational challenge with Bacillus cereus G9241. Palmer J; Bell M; Darko C; Barnewall R; Keane-Myers A Pathog Dis; 2014 Nov; 72(2):138-42. PubMed ID: 25044336 [TBL] [Abstract][Full Text] [Related]
52. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity. Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978 [TBL] [Abstract][Full Text] [Related]
53. A Biologically-Based Computational Approach to Drug Repurposing for Anthrax Infection. Bai JP; Sakellaropoulos T; Alexopoulos LG Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28287432 [TBL] [Abstract][Full Text] [Related]
56. Symmetry complementarity-guided design of anthrax toxin inhibitors based on β-cyclodextrin: Synthesis and relative activities of face-selective functionalized polycationic clusters. Díaz-Moscoso A; Méndez-Ardoy A; Ortega-Caballero F; Benito JM; Ortiz Mellet C; Defaye J; Robinson TM; Yohannes A; Karginov VA; García Fernández JM ChemMedChem; 2011 Jan; 6(1):181-92. PubMed ID: 21140396 [TBL] [Abstract][Full Text] [Related]
57. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009 [TBL] [Abstract][Full Text] [Related]
58. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates. Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514 [TBL] [Abstract][Full Text] [Related]
59. Monitoring endocytic trafficking of anthrax lethal factor by precise and quantitative protein labeling. Zheng S; Zhang G; Li J; Chen PR Angew Chem Int Ed Engl; 2014 Jun; 53(25):6449-53. PubMed ID: 24828812 [TBL] [Abstract][Full Text] [Related]
60. A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation. Melnyk RA; Collier RJ Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9802-7. PubMed ID: 16785422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]